A new solid-phase extraction (SPE) and quantitative determination of isoniazid (INH) and its acetyl metabolite (AcINH
Introduction
Isoniazid (INH) (Figure 1 ) is administrated with rifampicine, ethambutol, and pyrazinamide in tuberculosis treatment. It is metabolized by hepatic N-acetyltransferase to acetylisoniazid (AcINH), and the ratio AcINH-INH defines phenotypes into slow and rapid acetylors (1, 2) . Secondary effects of INH and its metabolites are detailed in the literature, depending of the acetylor phenotype (3, 4) . The therapeutic effectiveness and side effects of INH must then be related to its seric concentration. A number of analytical methods are described in the literature including brom o m e t ry (5) , nonaqueous titrimetry (6) , spectro p h o t o m e t ry (7) (8) (9) , chemiluminescence (10), fluorimetry (11) (12) (13) , colorimetry (14, 15) , gas chromatography (GC) (16) , and GC-mass spectro me t ry (17) . Since their introduction, high-perf o rmance liquid c h romatography (HPLC) methods have become more used (18) (19) (20) (21) (22) (23) (24) (25) (26) . We developed a high-perf o rmance thin-layer chromatography (HPTLC) of INH and AcINH with liquid-liquid extraction (27) . In this study, a new solid-phase extraction (SPE) combined with HPTLC is used to determine INH and its acetyl metabolite (AcINH) in serum. The results were compared with an HPLC technique.
Experimental Reagents
All solvents (spectroscopic grade) used were from Fluka (Buchs, Switzerland). INH and nicotinamide used as intern a l s t a n d a rd were from Hoffmann-LaRoche (Basel, Switzerland). AcINH was pre p a red and identified as described previously (23) .
Apparatus
A Waters chromatograph with a 600E pump (Milford, MA), 7625i Rheodyne injector with 20-µL sample loop (Rohnert Park,CA), and a Waters diode array detector 991 were used. Separations were carried out on a Novapak C 1 8 (150 × 4.6 mm) f rom Waters, preceded with a C 1 8 homemade guard column (2 × 0.4 cm). The mobile phase was: 0.1M phosphate buff e r (pH 7)-methanol (97.5:2.5, v/v). The flow rate was fixed to 1 mL/min. Data were collected with a Millenium 32 pro g r a m ( Waters). Quantitation was made at 254 nm. Thin-layer chromatography (TLC) was perf o rmed on 10-× 10-cm HPTLC plates precoated with silicagel 60 (layer thickness, 200 µm) (Merck ref. 5631). Samples were applied to the plate by means of a Camag microapplicator (Muttenz, Switzerland), 8 mm f rom the lower edge of the plate and 10 mm apart, starting 10 mm f rom the side of the plate; the distance between zones was 10 mm. Development was carried out in a linear developing chamber (Camag) and quantitated by densitometry with a TLC/HPTLC scanner (Camag). The running distance was fixed to 8 cm, and the t e m p e r a t u re was ambient. The measurement wavelength was 254 nm, the slit dimension 1 × 0.1 mm, and resolution 0.1 mm. Peak a reas were used for quantitation. Plates were developed with ethyl acetate-methanol (70:30, v/v).
Extraction of INH and AcINH from serum
SPE of the samples was carried on a poly(divinylbenzene-co-Nv i n y l p y rrolidone) cartridge (Oasis HLB, 60 mg, Waters). First, conditioning was made by flushing the cartridge with 1 mL methanol, 1 mL acetonitrile, and 1 mL 0.05M phosphate buff e r (pH 4.5). Then, 0.5 mL serum containing nicotinamide (5 mg/L) was applied by allowing it to pass through the bed with minimal suction, the cartridge washed with 1 mL 0.05M phosphate buff e r (pH, 4.5), and suctioned dry. Elution was made with 1 mL methanol-acetonitrile (1:1, v/v). The sample was then evaporated to dryness under nitrogen at 30°C and reconstituted with 100 µL methanol. One microliter was plotted to the HPTLC plate, and 20 µL was injected into the HPLC chro m a t o g r a p h .
Calibration
Calibration was accomplished using the following pro c e d u re . Ten 0.5-mL of blank sera was used, to which various INH and AcINH concentrations (0.5-10 mg/L) and a constant nicotinamide concentration (5 mg/L) were added. The samples were d e p roteinized, extracted, and analyzed as described pre v i o u s l y (the Extraction of INH and AcINH from serum subsection).
Limits of detection and quantitation
The detection limit (LOD) was estimated as the drug amount in s e rum that corresponded to four times the baseline noise. The limit of quantitation (LOQ) was determined as the lowest concentration of the calibration curv e .
Precision and accuracy
For spiked serum with diff e rent amounts of isoniazide, acetykisoniazide, and internal standard, the interrun precision of the selected method was estimated by calculating the coefficient of variation (CV) of the concentrations measured at diff e rent days (n = 6); the intrarun precision was determined the same way on the same day (n = 10). The accuracy was calculated as %bias.
Selectivity and specificity
To evaluate possible endogenous interf e re n c e s , five blank sera were analyzed with the pro p o s e d p ro c e d u re .
Results and Discussion

Calibration graph
Retention factors of isoniazide, acetylisoniazide, and nicotinamide are given in Table I . Calibration c u rves were obtained by least-squares linear re g ression analysis of the peak area ratio y of anal y t e -i n t e rnal standard versus analyte concentration x. The method was linear in the range 0.5-10 mg/L for INH and AcINH; their corre s p o n d i n g equations are given in Table I .
Recovery
The recoveries of INH and AcINH from spiked s e rum samples were calculated by comparing peak areas at low, medium, and high concentration levels with those obtained from the analysis of corresponding standard dilutions in methanol plotted directly to the HPTLC plate. The corresponding values are shown in Table I , which indicates a satisfying re c o v e ry of INH and AcINH in the concentration range studied.
Precision and accuracy
Table II summarizes the within-and betweenrun precision and accuracy for the determ i n a t i o n of INH and AcINH in spiked serum, as described in Table I 
Concentration
Wi t h i n B e t w e e n Wi t h i n B e t w e e n (µg/mL) (n = 3) Recovery (%) r u n r u n r u n r u n the Experimental section. Within-and between-run percent re l ative standard deviations (%RSD) (precision) by all the methods at low concentration were less than 7% and 5% at high concentration. The accuracy of the method expressed as %bias for within run, and between run were less than 93% at low and high conc e n t r a t i o n s .
Selectivity and specificity
Using the HPTLC chromatographic conditions, the other antit u b e rculosis drugs did not interf e re. Rifampicine and pyrazinamide retention factors were, re s p e c t i v e l y, 1 and 0.86. No endogenous or extraneous peaks were observed interfering with the assay of isoniazide.
LOD and LOQ
LOD at s/n = 4 and the LOQ, the lowest concentration of the calibration curve, are given in Table I .
Application of method
Several serum samples were analyzed by HPTLC and HPLC.
Typical chromatograms are shown in Figure 2 . The data presented in Figure 3 are indicative of a satisfactory corre l a t i o n between the results obtained from the two methods over the concentration range studied. The equations of the straight lines are given in Figure 3 .
Conclusion
The method described in this re p o rt has proved useful for the analysis of isoniazid and its seric metabolite AcINH in the concentration range 0.5-10 mg/L. It includes an SPE of the drug and its metabolite and their HPTLC on silica. The method was fully validated, accurate, and compared with the HPLC method. The HPTLC assay is more attractive because of its speed (appro x imately 30 min/10 samples) and simplicity. It can be used for ro utine analysis in the clinical laboratory to find precise acetylor phenotype by the ratio AcINH-INH or to determine INH seric c o n c e n t r a t i o n .
